StockNews.com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)
StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the stock. Moleculin Biotech Stock Performance Shares of Moleculin Biotech stock opened at $0.48 on Friday. The firm has a market cap of $14.43 million, a P/E ratio […]
More Stories
JPMorgan Chase & Co. (NYSE:JPM) Given New $325.00 Price Target at Bank of America
JPMorgan Chase & Co. (NYSE:JPM) had its price target increased by Bank of America from $300.00 to $325.00 in a...
Morgan Stanley Lowers PPL (NYSE:PPL) Price Target to $37.00
PPL (NYSE:PPL – Free Report) had its price objective lowered by Morgan Stanley from $38.00 to $37.00 in a research...
Restaurant Brands International (NYSE:QSR) Coverage Initiated by Analysts at Scotiabank
Scotiabank started coverage on shares of Restaurant Brands International (NYSE:QSR – Free Report) (TSE:QSR) in a research note released on...
Lennar (NYSE:LEN) Given New $146.00 Price Target at UBS Group
Lennar (NYSE:LEN – Free Report) had its price target decreased by UBS Group from $164.00 to $146.00 in a research...
Plains GP (NYSE:PAGP) Price Target Raised to $22.00
Plains GP (NYSE:PAGP – Free Report) had its price objective lifted by Mizuho from $20.00 to $22.00 in a research...
Centrus Energy (NYSE:LEU) Stock Price Expected to Rise, Evercore ISI Analyst Says
Centrus Energy (NYSE:LEU – Free Report) had its price target upped by Evercore ISI from $145.00 to $205.00 in a...